1. Home
  2. IMOS vs LXRX Comparison

IMOS vs LXRX Comparison

Compare IMOS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMOS
  • LXRX
  • Stock Information
  • Founded
  • IMOS 1997
  • LXRX 1995
  • Country
  • IMOS Taiwan
  • LXRX United States
  • Employees
  • IMOS N/A
  • LXRX N/A
  • Industry
  • IMOS Semiconductors
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMOS Technology
  • LXRX Health Care
  • Exchange
  • IMOS Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • IMOS 813.1M
  • LXRX 650.7M
  • IPO Year
  • IMOS N/A
  • LXRX 2000
  • Fundamental
  • Price
  • IMOS $19.52
  • LXRX $0.98
  • Analyst Decision
  • IMOS
  • LXRX Buy
  • Analyst Count
  • IMOS 0
  • LXRX 2
  • Target Price
  • IMOS N/A
  • LXRX $6.00
  • AVG Volume (30 Days)
  • IMOS 21.2K
  • LXRX 4.3M
  • Earning Date
  • IMOS 11-05-2024
  • LXRX 11-12-2024
  • Dividend Yield
  • IMOS 5.70%
  • LXRX N/A
  • EPS Growth
  • IMOS 7.03
  • LXRX N/A
  • EPS
  • IMOS 0.07
  • LXRX N/A
  • Revenue
  • IMOS $724,842,895.00
  • LXRX $5,229,000.00
  • Revenue This Year
  • IMOS $15.65
  • LXRX $1,212.46
  • Revenue Next Year
  • IMOS $13.49
  • LXRX $219.10
  • P/E Ratio
  • IMOS $13.73
  • LXRX N/A
  • Revenue Growth
  • IMOS 13.31
  • LXRX 886.60
  • 52 Week Low
  • IMOS $19.27
  • LXRX $0.97
  • 52 Week High
  • IMOS $32.19
  • LXRX $3.73
  • Technical
  • Relative Strength Index (RSI)
  • IMOS 26.95
  • LXRX 25.78
  • Support Level
  • IMOS $19.27
  • LXRX $1.01
  • Resistance Level
  • IMOS $21.76
  • LXRX $1.35
  • Average True Range (ATR)
  • IMOS 0.30
  • LXRX 0.12
  • MACD
  • IMOS -0.25
  • LXRX -0.06
  • Stochastic Oscillator
  • IMOS 8.41
  • LXRX 0.43

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: